Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11526
PUT
InfraCap MLP ETF
AMZA
$463M
| $94.1K | ﹤0.01% |
2,200
+600
| +38% | +$25.4K |
2021 Q1
15 quarters
|
|
|
GB
11527
DELISTED
Global Blue Group Holding
GB
| $94K | ﹤0.01% |
13,563
-4,319
| -24% | -$24.8K |
2023 Q2
6 quarters
|
|
11528
CALL
Ameris Bancorp
ABCB
$5.29B
| $93.9K | ﹤0.01% |
1,500
-3,100
| -67% | -$203K |
2022 Q3
9 quarters
|
|
|
11529
PUT
Ameris Bancorp
ABCB
$5.29B
| $93.9K | ﹤0.01% |
1,500
-900
| -38% | -$59K |
2022 Q1
11 quarters
|
|
|
SEMR
11530
CALL
DELISTED
Semrush
SEMR
| $93.9K | ﹤0.01% |
7,900
+1,100
| +16% | +$14.8K |
2023 Q1
7 quarters
|
|
11531
AN2 Therapeutics
ANTX
$183M
| $93.8K | ﹤0.01% |
+67,994
| New | +$82.5K |
2024 Q4
0 quarters
|
|
11532
MDB Capital Holdings
MDBH
$20.9M
| $93.8K | ﹤0.01% |
+14,884
| New | +$101K |
2024 Q4
0 quarters
|
|
11533
CALL
ProShares Ultra Real Estate
URE
$46.4M
| $93.8K | ﹤0.01% |
1,500
-700
| -32% | -$49.6K |
2022 Q4
8 quarters
|
|
11534
CALL
DarioHealth
DRIO
$59.6M
| $93.7K | ﹤0.01% |
5,960
+745
| +14% | +$12.9K |
2021 Q2
14 quarters
|
|
|
INVX
11535
PUT
Innovex International
INVX
$1.88B
| $93.6K | ﹤0.01% |
6,700
-1,500
| -18% | -$22.5K |
2022 Q4
8 quarters
|
|
11536
CuriosityStream
CURI
$175M
| $93.5K | ﹤0.01% |
61,140
-27,256
| -31% | -$52.5K |
2024 Q3
1 quarter
|
|
|
EDF
11537
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$153M
| $93.5K | ﹤0.01% |
+19,899
| New | +$99.6K |
2024 Q4
0 quarters
|
|
|
LKFT
11538
CALL
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.96B
| $93.5K | ﹤0.01% |
3,400
-11,200
| -77% | -$312K |
2019 Q1
23 quarters
|
|
11539
CALL
Corporacion America
CAAP
$4.05B
| $93.3K | ﹤0.01% |
5,000
-24,300
| -83% | -$457K |
2022 Q4
8 quarters
|
|
11540
CALL
iShares MSCI World ETF
URTH
$8.28B
| $93.3K | ﹤0.01% |
600
| – | – |
2024 Q3
1 quarter
|
|
|
TRST
11541
PUT
Trustco Bank Corp NY
TRST
$924M
| $93.3K | ﹤0.01% |
2,800
+1,400
| +100% | +$48.7K |
2024 Q1
3 quarters
|
|
11542
CALL
LSI Industries
LYTS
$778M
| $93.2K | ﹤0.01% |
4,800
+2,600
| +118% | +$48.2K |
2022 Q4
8 quarters
|
|
11543
CALL
Dr. Reddy's Laboratories
RDY
$10.2B
| $93.2K | ﹤0.01% |
5,900
-11,100
| -65% | -$167K |
2022 Q4
8 quarters
|
|
11544
Champions Oncology
CSBR
$67.9M
| $93.1K | ﹤0.01% |
+10,868
| New | +$54.7K |
2024 Q4
0 quarters
|
|
11545
PUT
Stock Yards Bancorp
SYBT
$2.35B
| $93.1K | ﹤0.01% |
+1,300
| New | +$91.6K |
2024 Q4
0 quarters
|
|
11546
CALL
HEICO Corp Class A
HEI.A
$30.9B
| $93K | ﹤0.01% |
500
+200
| +67% | +$40.3K |
2022 Q3
9 quarters
|
|
|
MHI
11547
DELISTED
Pioneer Municipal High Income Fund
MHI
| $93K | ﹤0.01% |
+10,046
| New | +$95K |
2024 Q4
0 quarters
|
|
|
NOAH
11548
Noah Holdings
NOAH
$531M
| $92.9K | ﹤0.01% |
+7,930
| New | +$98.2K |
2024 Q4
0 quarters
|
|
11549
Precision Optics
POCI
$49.6M
| $92.7K | ﹤0.01% |
+19,242
| New | +$90.9K |
2024 Q4
0 quarters
|
|
11550
PUT
Schwab US Large- Cap ETF
SCHX
$75.2B
| $92.7K | ﹤0.01% |
4,000
+1,000
| +33% | +$23.3K |
2022 Q4
8 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.